ES2066239T3 - Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen. - Google Patents

Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen.

Info

Publication number
ES2066239T3
ES2066239T3 ES91101425T ES91101425T ES2066239T3 ES 2066239 T3 ES2066239 T3 ES 2066239T3 ES 91101425 T ES91101425 T ES 91101425T ES 91101425 T ES91101425 T ES 91101425T ES 2066239 T3 ES2066239 T3 ES 2066239T3
Authority
ES
Spain
Prior art keywords
complexes
bilobalid
phospholipidic
formulates
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91101425T
Other languages
English (en)
Inventor
Ezio Bombardelli
Giuseppe Mustich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2066239T3 publication Critical patent/ES2066239T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE DESCRIBEN UNOS COMPLEJOS ENTRE FOSFOLIPIDOS NATURALES O SINTETICOS Y LA BILOBALIDA, Y UN SESQUITERPENO EXTRAIDO DE LAS HOJAS DE "GINGKO BILOBA", ASI COMO LA PREPARACION DE LOS MISMOS Y SUS APLICACIONES TERAPEUTICAS COMO AGENTES ANTIINFLAMATORIOS Y COMO SUSTANCIAS PARA EL TRATAMIENTO DE LAS ALTERACIONES RELACIONADAS CON LOS PROCESOS INFLAMATORIOS O TRAUMATICOS NEURONALES. ESTOS NUEVOS COMPUESTOS, LOS CUALES TIENEN UNA DISPONIBILIDAD BIOLOGICA DIFERENTE A LA QUE TIENE LA BILOBALIDA, SON ADECUADOS PARA INCORPORARLOS EN LAS FORMULACIONES FARMACEUTICAS TANTO PARA LA ADMINISTRACION TOPICA COMO SISTEMATICA: ESTA ULTIMA VIA SE HA DESCUBIERTO QUE ES PARTICULARMENTE UTIL PARA EL TRATAMIENTO DE LAS ALTERACIONES PERIFERICAS MAS COMUNES ASOCIADAS CON LAS ALTERACIONES INFLAMATORIAS O NEURODISTROFICAS.
ES91101425T 1990-02-09 1991-02-07 Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen. Expired - Lifetime ES2066239T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19324A IT1238684B (it) 1990-02-09 1990-02-09 Derivati del bilobalide,loro usi e formulazioni che li contegono

Publications (1)

Publication Number Publication Date
ES2066239T3 true ES2066239T3 (es) 1995-03-01

Family

ID=11156741

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91101425T Expired - Lifetime ES2066239T3 (es) 1990-02-09 1991-02-07 Complejos fosfolipidicos de bilobalido, sus aplicaciones y formulados que los contienen.

Country Status (11)

Country Link
US (1) US5202313A (es)
EP (1) EP0441279B1 (es)
JP (1) JP3036881B2 (es)
KR (1) KR0170773B1 (es)
AT (1) ATE115585T1 (es)
CA (1) CA2035951C (es)
DE (1) DE69105767T2 (es)
DK (1) DK0441279T3 (es)
ES (1) ES2066239T3 (es)
HK (1) HK160795A (es)
IT (1) IT1238684B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
EP0540766A1 (en) * 1991-11-04 1993-05-12 Korth, Ruth-Maria, Dr. med Treatment of eosinophil-mediated diseases with Paf antagonists and procedure for determining their efficacy.
DE540767T1 (de) * 1991-11-04 2001-10-25 Ruth-Maria Korth Behandlung und Vorbeugung von von erhöhten Lyso-PAF-Spiegel mediierten mentalen Erkrankungen mit PAF-Antagonisten
GB9202993D0 (en) * 1992-02-13 1992-03-25 Indena Spa Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
US5456912A (en) * 1993-12-28 1995-10-10 The Regents Of The University Of California Non-methylene interrupted fatty acids as immunomodulators
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
WO1999064028A1 (en) * 1998-06-11 1999-12-16 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Protecting neurons from ischemia
US7494643B2 (en) * 2003-07-22 2009-02-24 Rendon Marta I Method and topical composition for the treatment of hyperpigmented skin
SI1559430T1 (sl) * 2004-01-29 2009-08-31 Indena Spa Uporaba kompleksov ginkga za izboljĺ anje kognitivnih funkcij in ublaĺ˝itev duĺ evne izäśrpanosti
ITMI20060136A1 (it) * 2006-01-27 2007-07-28 Pharmextracta S R L Composizioni a base di derivati della ginkgo biloba per il trattamento di condizioni asmatiche e allergiche
ITMI20071492A1 (it) 2007-07-24 2009-01-25 S I I T Srl Servizio Internazi "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba"
IT1397386B1 (it) 2010-01-12 2013-01-10 Indena Spa Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso.
IT1402672B1 (it) 2010-11-08 2013-09-13 Medestea Biotech S P A Composizioni comprendenti principi attivi di origine vegetale associati o meno a promotori e/o protettori di ossido nitrico per il trattamento e la prevenzione dei deficit erettili e dell' impotenza e per il potenziamento della performance sportiva
ITTO20110901A1 (it) 2011-10-10 2013-04-11 Medestea Biotech S P A Composizione sinergica per la prevenzione ed il trattamento di disturbi connessi all'invecchiamento
CN109851634B (zh) * 2018-12-25 2020-12-22 华东师范大学 手性单膦配体Yu-Phos及其全构型的制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DD213672A1 (de) * 1983-03-04 1984-09-19 Akad Wissenschaften Ddr Verfahren zur herstellung von gibberellin-derivaten mit 13,16-anneliertem oxathiaphospholan-ring
IT1215291B (it) * 1985-07-17 1990-01-31 Inverni Della Beffa Spa Complessi di flavanolignani con fosfolipidi, loro preparazione e relative composizioni farmaceutiche.
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
JPH0231648A (ja) * 1988-07-21 1990-02-01 Daicel Chem Ind Ltd イチョウ抽出物入りチューインガム
JPH0231646A (ja) * 1988-07-21 1990-02-01 Daicel Chem Ind Ltd イチョウ抽出物入りチョコレート

Also Published As

Publication number Publication date
JPH06145174A (ja) 1994-05-24
IT1238684B (it) 1993-09-01
EP0441279A1 (en) 1991-08-14
KR0170773B1 (ko) 1999-03-30
DK0441279T3 (da) 1995-05-08
HK160795A (en) 1995-10-20
DE69105767T2 (de) 1995-04-27
US5202313A (en) 1993-04-13
CA2035951A1 (en) 1991-08-10
CA2035951C (en) 2001-07-31
KR910015308A (ko) 1991-09-30
ATE115585T1 (de) 1994-12-15
EP0441279B1 (en) 1994-12-14
IT9019324A1 (it) 1991-08-09
JP3036881B2 (ja) 2000-04-24
DE69105767D1 (de) 1995-01-26
IT9019324A0 (it) 1990-02-09

Similar Documents

Publication Publication Date Title
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
CU23393A3 (es) Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen
MX9301129A (es) Nuevas ciclosporinas y composiciones farmaceuticas que las contienen.
NO854085L (no) Liposomer fra syntetiske lipider.
GT199700095A (es) Derivados 6,5-heterobiciclicos sustituidos.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
MX9305934A (es) Nuevo modificador de resistencia a drogas multiples.
CO5160262A1 (es) Formulaciones farmaceuticas de liberacion controlada
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ATE56021T1 (de) Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
MX9400175A (es) Derivados de fenil tri-substituidos y proceso para su preparacion.
GT199800083A (es) Agonistas de prostaglandinas.
PT87081A (pt) Controlled release formulations
ES2126766T3 (es) 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo.
AR010700A1 (es) Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene
ES2108698T3 (es) Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis.
MX9401295A (es) Fosfonatos sustituidos, los procedimientos para supreparacion y composiciones farmaceuticas que los contienen.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
DK0441279T3 (da) Bilobalid-phospholipid-komplekser, deres anvendelse og sammensætninger, der indeholder dem
ES2123499T3 (es) Metodos y composiciones para tratamiento de infecciones virales.
AR008781A1 (es) Compuestos de furano nitrona
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 441279

Country of ref document: ES